Cargando…
Discovery of over 200 new and expanded genetic conditions using GeneMatcher
GeneMatcher is a platform through which various stakeholders can connect with others interested in candidate gene findings. GeneDx, a diagnostic laboratory, has utilized GeneMatcher over the last seven years to successfully facilitate connections between clinicians and researchers, generating fruitf...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306743/ https://www.ncbi.nlm.nih.gov/pubmed/35224800 http://dx.doi.org/10.1002/humu.24351 |
_version_ | 1784752609798651904 |
---|---|
author | McWalter, K. Torti, E. Morrow, M. Juusola, J. Retterer, K. |
author_facet | McWalter, K. Torti, E. Morrow, M. Juusola, J. Retterer, K. |
author_sort | McWalter, K. |
collection | PubMed |
description | GeneMatcher is a platform through which various stakeholders can connect with others interested in candidate gene findings. GeneDx, a diagnostic laboratory, has utilized GeneMatcher over the last seven years to successfully facilitate connections between clinicians and researchers, generating fruitful research collaborations. Our ultimate goal in reporting candidate gene findings is to amass sufficient evidence to establish novel disease–gene relationships (DGRs), thus providing diagnostic answers to families and clinicians. Our database of over 300,000 clinical exomes has been a major driver of DGR discovery. Our laboratory accounts for over 20% of total GeneMatcher submissions. Largely fueled by GeneMatcher matches, we have published over 200 articles involving new DGRs or expanded phenotypes for known disease‐causing genes in the past three years. These endeavors require commitments to sharing data and dedicating resources to investigate potential matches. Ultimately, GeneMatcher enables collaboration on a broad scale: we are grateful to the clinicians, researchers, patients, and caregivers who have partnered with us to accelerate the pace of DGR discovery. GeneMatcher opens the door to new partnerships, new discoveries, and families finding answers that otherwise may not have been possible. |
format | Online Article Text |
id | pubmed-9306743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93067432022-07-28 Discovery of over 200 new and expanded genetic conditions using GeneMatcher McWalter, K. Torti, E. Morrow, M. Juusola, J. Retterer, K. Hum Mutat Special Articles GeneMatcher is a platform through which various stakeholders can connect with others interested in candidate gene findings. GeneDx, a diagnostic laboratory, has utilized GeneMatcher over the last seven years to successfully facilitate connections between clinicians and researchers, generating fruitful research collaborations. Our ultimate goal in reporting candidate gene findings is to amass sufficient evidence to establish novel disease–gene relationships (DGRs), thus providing diagnostic answers to families and clinicians. Our database of over 300,000 clinical exomes has been a major driver of DGR discovery. Our laboratory accounts for over 20% of total GeneMatcher submissions. Largely fueled by GeneMatcher matches, we have published over 200 articles involving new DGRs or expanded phenotypes for known disease‐causing genes in the past three years. These endeavors require commitments to sharing data and dedicating resources to investigate potential matches. Ultimately, GeneMatcher enables collaboration on a broad scale: we are grateful to the clinicians, researchers, patients, and caregivers who have partnered with us to accelerate the pace of DGR discovery. GeneMatcher opens the door to new partnerships, new discoveries, and families finding answers that otherwise may not have been possible. John Wiley and Sons Inc. 2022-02-27 2022-06 /pmc/articles/PMC9306743/ /pubmed/35224800 http://dx.doi.org/10.1002/humu.24351 Text en © 2022 GeneDx. Human Mutation published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Special Articles McWalter, K. Torti, E. Morrow, M. Juusola, J. Retterer, K. Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title | Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title_full | Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title_fullStr | Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title_full_unstemmed | Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title_short | Discovery of over 200 new and expanded genetic conditions using GeneMatcher |
title_sort | discovery of over 200 new and expanded genetic conditions using genematcher |
topic | Special Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306743/ https://www.ncbi.nlm.nih.gov/pubmed/35224800 http://dx.doi.org/10.1002/humu.24351 |
work_keys_str_mv | AT mcwalterk discoveryofover200newandexpandedgeneticconditionsusinggenematcher AT tortie discoveryofover200newandexpandedgeneticconditionsusinggenematcher AT morrowm discoveryofover200newandexpandedgeneticconditionsusinggenematcher AT juusolaj discoveryofover200newandexpandedgeneticconditionsusinggenematcher AT rettererk discoveryofover200newandexpandedgeneticconditionsusinggenematcher |